Skip to content

Clinical trials

Phase 1 Thyroid Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Phase: Phase 1 Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20031
20041
20053
20064
20072
20083
20113
20124
20131
20143
20153
20172
20183
20191
20205
20215
20225
20233
20241
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Active, not recruiting10
Recruiting10
Terminated10
Withdrawn2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center7
National Cancer Institute (NCI)5
M.D. Anderson Cancer Center3
Celgene2
Eli Lilly and Company2
European Organisation for Research and Treatment of Cancer - EORTC2
Jonsson Comprehensive Cancer Center2
Pfizer2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
University of Colorado, Denver2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms67
Melanoma23
Breast Neoplasms22
Carcinoma, Non-Small-Cell Lung18
Pancreatic Neoplasms16
Prostatic Neoplasms16
Colorectal Neoplasms15
Ovarian Neoplasms15
Head and Neck Neoplasms13
Lung Neoplasms13

Trials

Showing 26 to 50 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.